Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colorectal cancer.
(click here for details)
(in collaboration with the CRUK Clinical Trials Unit ,Glasgow) Short Course Oncology Therapy - A study of adjuvant chemotherapy in colorectal cancer by the CACTUS and QUASAR 3 groups.
(click here for details)
Conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme.
(click here for details)
Randomised phase III trial of gefitinib 500 mg once daily versus placebo in oesophageal cancer progressing after chemotherapy.
(click here for details)
Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring: Pilot Study of Optimal Dose Scheduling of Capecitabine for Patients with Metastatic Colorectal or Metastatic Breast Cancer.
(click here for details)
An open-label randomised phase II trial of 5-Fluorouracil, OXaliplatin and Folinic acid +/- Interventional Radio-Embolisation as first line treatment of patients with liver dominant metastatic disease from colorectal cancer.
(click here for details)
